Ironwood Enters into Definitive Agreement to Acquire VectivBio

2023

May 22

Written By Guest User

Guest User

enGene (Nasdaq: ENGN) Launched as Publicly Traded Genetic Medicines Company

Amolyt Pharma Announces $138 Million Series C Financing led by Sofinnova Partners and co-led by Intermediate Capital Group